Schooley has 35 years of experience in the pharmaceutical industry, with a
focus on clinical and regulatory affairs, and he has been associated with
product development and approvals of 19 marketed drugs in the U.S., Europe and
Pacific Rim countries.
positions include Director of Clinical Research at Allergan, V.P. of Clinical
Research & Regulatory Affairs at Newport Pharmaceuticals International,
V.P. of Clinical Research & Regulatory Affairs at Alliance Pharmaceutical
Corp. and CSO and Senior V.P. of Clinical Development & Regulatory Affairs
at Skye Pharma-Pacira Pharmaceuticals. He has
participated in multiple product approvals in the U.S., Canada, Australia and
Europe, including those for DepoCyte, 5-flurouracil, Solarize and
Alprazolam. He also has experience in oncology, including hepatic carcinoma,
neoplastic meningitis and glioblastoma.
Schooley received his undergraduate training and M.S. at Brigham Young
University and Ph.D. in Biostatistics and Medical Care Organization &
Administration at the University of Michigan, School of Public Health.